Completed

Screening Study for the Evaluation and Diagnosis of Potential Research Subjects With Anterior Segment Disease

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being collected

Data Collection

Who is being recruted

Eye Diseases

See all eligibility criteria
How is the trial designed

Observational
Study Start: July 2004
See protocol details

Summary

Principal SponsorNational Eye Institute (NEI)
Last updated: January 14, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: July 13, 2004

Actual date on which the first participant was enrolled.

This is a screening protocol that will allow the NEI clinicians to examine patients with ocular diseases in order to identify those who may be eligible to participate in other NEI studies on anterior segment disease.

Official TitleScreening Study for the Evaluation and Diagnosis of Potential Research Subjects With Anterior Segment Disease 
NCT00088348
Principal SponsorNational Eye Institute (NEI)
Last updated: January 14, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

600 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Eye Diseases

Criteria

* ELIGIBILITY CRITERIA: To participate in this screening study, a patient must have a history of anterior segment disease. Patients of all ages are eligible.

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Suspended

National Institutes of Health Clinical Center, 9000 Rockville Pike

Bethesda, United StatesSee the location
CompletedOne Study Center